Population (Patient/Control) Allele Genotype OR 95% CI P value VDR variation between PD and healthy control Reference
Korean (137/163) rs1544410 A GG vs GA+AA 0.917 0.438–1.919 0.818 No significant difference for BsmI [26]
rs731236 C TT vs TC+CC 1.390 0.680-2.842 0.366 No significant difference for TaqI
rs7976091T CC vs CT+TT 1.574 0.961-2.579 0.071 No significant difference for ApaI
rs2228570 T CC vs CT+TT 0.826 0.506-1.347 0.443 No significant difference for FokI
Chinese (470/470)
rs2228570
A vs G
1.289
1.074-1.547
0.006
Significant; increased risk for A allele
[27]
AA vs GG+GA 1.707 1.239-2.353 0.001
AA vs GG 1.741 1.201-2.524 0.003
Chinese (260/282) FokI C allele 1.340 1.044-1.720 0.023 Significant association in PD [28]
CC+TC vs TT 2.164 1.264-3.703 0.004 Significant difference between patient and control
CC vs CT+TT 1.139 0.880-1.331 0.223
BsmI AA+AG vs GG 1.099 0.677-1.785 0.712 No significant difference
AA vs AG +GG 2.188 0.397-10.04 0.434
Iran 150/160 ApaI TG+GG 7.7 3.2-18.38 <0.0001 TG genotype significantly increased in PD [29]
FokI TT+CT 7.7 3.2-18.38 0.85 No difference between PD and control
Faroese 121/231 ApaI rs7975232 AC 1.14 0.67-1.92 0.64 No significant association between VDR polymorphism in PD patients [30]
CC 1.31 0.70-2.50 0.40
AC+CC 1.19 0.72-2.0 0.50
A 1.14 0.83-1.56 0.41
BsmI rs1544410 AG 1.3 0.78-2.04 0.34 No significant association between VDR polymorphism in PD patients
AA 0.97 0.50-1.87 0.93
AG+AA 1.18 0.75-1.86 0.47
G 1.04 0.76-1.43 0.81
TaqI CT 1.28 0.79-2.01 0.32 No significant association between VDR polymorphism in PD patients
CC 0.99 0.51-1.90 0.97
CT+CC 1.2 0.76-1.90 0.43
T 1.05 0.76-1.44 0.77
Taiwanese 700/792 rs2853599 AA+GA vs GG 0.85 0.68-1.06 0.16 No significant association between VDR polymorphism in PD patients [31]
rs4334089 AA+GA vs GG 1.06 0.86-1.31 0.57
rs7299460 TT+CT vs CC 1.12 0.89-1.42 0.33
rs7968585 CC+CT vs TT 1.02 0.83-1.25 0.86
rs7976091 TT+CT vs CC 0.92 0.73-1.16 0.49
rs10083198 CT+TT vs CC 1.07 0.86-1.33 0.57
Japanese 137/none FokI CC vs CT + TT 0.33 0.17-0.67 0.002 FokICC linked with PD onset [32]
BsmI AA vs AG+ GG 0.34 0.09-1.29 0.11 No significant difference for BsmI
ApaI GG vs GT+TT 1.23 0.63-2.43 0.55 No significant difference for ApaI
TaqI TT vs TC + CC 1.570 0.70-3.53 0.23 No significant difference for TaqI
Hungarian FokI CC+CT vs TT 2.677 1.214-5.91 0.015 Significantly higher in PD patients than control [33]
C allele 1.615 1.087-2.399 0.017 Significant association with PD group.
BsmI GG vs AA+AG 0.890 0.478-1.654 0.753 No significant difference between patient and control
Allele frequency 0.977 0.665-1.434 0.905
TaqI TT+TC vs CC 0.840 0.399-1.767 0.646 No significant difference between patient and control
Allele frequency 0.802 0.540-1190 0.273
ApaI GG vs TT+TG 1.352 0.654-2.796 0.466 No significant difference between patient and control
Allele frequency 1.177 0.793-1.748 0.417